|
|
|
Financials-Merck Limited| Sector: Bulk Drugs and Formulations | | BSE:500126 | NSE:MERCK | Bloomberg:EMER@IN | Reuters:MERK.BO | | Market Lot: 1 | Face Value: 10 | ISIN Demat: INE199A01012 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Mar-2021(3) |
31-Mar-2020(3) |
% Change |
| Sales of Products/Services |
2191.50 |
2281.06 |
-3.93 |
| Other Operating Income |
0.00 |
0.00 |
-- |
| Other Income |
32.40 |
102.63 |
-68.43 |
| Total Income |
2223.90 |
2383.69 |
-6.70 |
| Total Expenses |
-1962.90 |
-1736.05 |
13.07 |
| OPBDIT |
4186.80 |
4119.74 |
1.63 |
| Interest |
0.00 |
0.00 |
-- |
| Depreciation |
-76.70 |
-1736.05 |
-95.58 |
| Exceptional & Extraordinary Items |
0.00 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
-103.30 |
-183.02 |
-43.56 |
| After Tax Profit |
157.70 |
464.62 |
-66.06 |
| Equity Capital |
0.00 |
0.00 |
-- |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
|
|
|
|
| As on( Months ) |
31-Dec-05(12) |
|
31-Dec-04(12) |
|
31-Dec-03(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
3938.60 |
98.13 |
3766.00 |
98.88 |
3625.20 |
99.29 |
| Operating Income (OI) |
4013.80 |
100.00 |
3808.70 |
100.00 |
3651.30 |
100.00 |
| OPBDIT |
1139.80 |
28.40 |
1078.20 |
28.31 |
959.70 |
26.28 |
| OPBDT |
1145.60 |
28.54 |
1081.30 |
28.39 |
951.60 |
26.06 |
| OPBT |
1068.10 |
26.61 |
995.30 |
26.13 |
855.50 |
23.43 |
| Non-Operating Income |
104.50 |
2.60 |
90.50 |
2.38 |
80.30 |
2.20 |
| Extraordinary/Prior Period |
-2.00 |
-0.05 |
-10.90 |
-0.29 |
-259.40 |
-7.10 |
| Tax |
382.70 |
9.53 |
365.00 |
9.58 |
280.00 |
7.67 |
| Profit after tax(PAT) |
787.90 |
19.63 |
709.90 |
18.64 |
396.40 |
10.86 |
| Cash Profit |
865.40 |
21.56 |
795.90 |
20.90 |
492.50 |
13.49 |
| Dividend-Equity |
252.90 |
6.30 |
168.60 |
4.43 |
168.60 |
4.62 |
|
| As on |
31-Dec-05 |
|
31-Dec-04 |
|
31-Dec-03 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
1065.30 |
27.50 |
1041.20 |
32.01 |
1219.70 |
44.42 |
| Net Block |
430.40 |
11.11 |
448.10 |
13.78 |
580.80 |
21.15 |
| Capital WIP |
17.00 |
0.44 |
6.30 |
0.19 |
1.10 |
0.04 |
| Investments |
1406.70 |
36.31 |
1172.80 |
36.06 |
0.00 |
0.00 |
| Inventory |
419.00 |
10.82 |
381.20 |
11.72 |
408.40 |
14.87 |
| Receivables |
555.30 |
14.33 |
493.80 |
15.18 |
520.80 |
18.97 |
| Other Current Assets |
1045.70 |
26.99 |
750.50 |
23.07 |
1234.80 |
44.97 |
| Balance Sheet Total(BT) |
3874.10 |
100.00 |
3252.70 |
100.00 |
2745.90 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
168.60 |
4.35 |
168.60 |
5.18 |
168.60 |
6.14 |
| Reserves |
2812.70 |
72.60 |
2296.00 |
70.59 |
1759.30 |
64.07 |
| Total Debt |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Creditors and Acceptances |
195.40 |
5.04 |
225.30 |
6.93 |
277.60 |
10.11 |
| Other current liab/prov. |
697.40 |
18.00 |
562.80 |
17.30 |
540.40 |
19.68 |
| Balance Sheet Total(BT) |
3874.10 |
100.00 |
3252.70 |
100.00 |
2745.90 |
100.00 |
|
| As on |
31-Dec-05 |
31-Dec-04 |
31-Dec-03 |
| OPBIT/Prod.cap.empl.(%) |
68.20 |
82.31 |
71.84 |
| PBIT/Cap. Employed (%) |
39.29 |
43.60 |
35.53 |
| PAT/Networth (%) |
26.43 |
28.80 |
20.56 |
| Tax/PBT (%) |
32.69 |
33.96 |
41.40 |
| Total Debt/Networth (x) |
0.00 |
0.00 |
0.00 |
| Long Term Debt/Networth (x) |
0.00 |
0.00 |
0.00 |
| PBDIT/Finance Charges (x) |
-214.19 |
-373.48 |
96.37 |
| Current Ratio (x) |
2.26 |
2.06 |
2.65 |
| RM Inventory (days consumption) |
51.36 |
43.92 |
46.04 |
| FG inventory (days cost of sales) |
35.17 |
35.29 |
39.12 |
| Receivables (days gross sales) |
46.71 |
43.41 |
47.53 |
| Creditors (days cost of sales) |
24.82 |
30.12 |
37.64 |
| Op. curr. assets (days OI) |
180.00 |
142.00 |
135.00 |
|
|
Financials